18:32 , Nov 30, 2018 |  BC Week In Review  |  Company News

Immunocore, Genentech team up to bring soluble TCR therapy into clinic

Despite losing at least five key executives this year, Immunocore Ltd. (Abingdon, U.K.) has teamed up with Genentech Inc. to advance the first soluble TCR-based therapy from their existing deal into clinical testing for solid...
23:15 , Nov 19, 2018 |  BC Extra  |  Company News

Immunocore, Genentech team up to bring soluble TCR therapy into clinic

Despite losing at least five key executives this year, Immunocore Ltd. (Abingdon, U.K.) has teamed up with Genentech Inc. to advance the first soluble TCR-based therapy from their existing deal into clinical testing for solid...
22:34 , Sep 4, 2018 |  BC Extra  |  Financial News

Another C-suite departure at Immunocore

Chief Strategy and Business Officer Kevin Pojasek has left Immunocore Ltd. (Abingdon, U.K.) to join SV Health Investors as venture partner. Pojasek is the fifth C-level executive to leave the TCR company since former CEO...
21:09 , Jul 16, 2018 |  BC Extra  |  Company News

Management tracks: Cerecor, Sangamo

Neurology play Cerecor Inc. (NASDAQ:CERC) said CFO Mariam Morris is stepping down. She is succeeded by Joe Miller, who was VP of finance at Sucampo Pharmaceuticals Inc., which Mallinckrodt plc (NYSE:MNK) acquired. Additionally, Cerecor hired...
20:17 , Aug 16, 2017 |  BC Innovations  |  Emerging Company Profile

Aiming horizontal

SciBac Inc. is using old-school genetics to make therapeutic bacteria that can battle pathogenic organisms and antibiotic-resistant infections. The approach uses horizontal gene transfer to move therapeutic genes from newly discovered species into strains already...
07:00 , Oct 13, 2016 |  BC Innovations  |  Translation in Brief

Dodging CARs

Scientists at NIH's National Cancer Institute have discovered a new way in which acute lymphoblastic leukemia (ALL) cells become resistant to CAR T cell therapy: by changing into myeloid cells. The results highlight the remarkable...
07:00 , Oct 12, 2016 |  BC Extra  |  Company News

Management tracks

T cell receptor (TCR) therapy company Immunocore Ltd. (Abingdon, U.K.) hired Paul Fry as CFO. He was director of global finance operations at Vodafone Group plc (NASDAQ:VOD). Global Blood Therapeutics Inc. (NASDAQ:GBT) hired Tricia Suvari...
07:00 , Sep 23, 2013 |  BioCentury  |  Finance

Analyst tracks

Analyst tracks Ian Somaiya will join Nomura in November as a managing director and senior analyst covering U.S. biotechnology. Somaiya was a managing director and lead biotechnology analyst at Piper Jaffray. Banker tracks Peter Fry...
07:00 , Jul 9, 2012 |  BC Week In Review  |  Company News

GeneAssess cancer news

GeneAssess received a commitment for up to $500,000 in pre-seed funding from not-for-profit Foundation Venture Capital Group (FVCG). The newco, which was spun out of the University of Medicine and Dentistry of New Jersey in...
08:00 , Jan 2, 2012 |  BioCentury  |  Finance

Small-fry squashed

Among last year's best-performing large cap biotechs were an acquiree and an acquirer: HCV play Pharmasset Inc. and Valeant Pharmaceuticals International Inc. Other big cap stocks also did well overall, while investors abandoned their small-...